- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 20, 2025 | 41.25M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 222.95M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 222.07M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$1.89M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.11M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $99.14K |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $3.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$8.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$4.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $5.3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $22.05M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $18.81M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $27.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $24.68M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.62M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.65M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $26.93M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $27.81M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.02 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $212K |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $342.25K |
| Net Income | Q1 2025 · Mar 31, 2025 | −$5.34M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.26M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$2M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.9M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | −$188.6K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | −$278.89K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $1.94M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.47M |
| Revenue | Q1 2025 · Mar 31, 2025 | $1.75M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.19M |
| Capex | Q1 2025 · Mar 31, 2024 | $734.92K |